Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial
暂无分享,去创建一个
C. Held | P. Armstrong | F. Van de Werf | H. White | K. Mahaffey | L. Wallentin | M. Valgimigli | R. Harrington | P. Aylward | D. Moliterno | Y. Lokhnygina | P. Tricoci | F. Costa | R. Clare